FDA CERSI Lecture Series | UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI)

Date	Speaker	Talk Title
3/12/26	Russ Altman, MD, MPH Stanford University	Large Language Models to Support Bioequivalence Evaluation
1/23/24	Janice B. Schwartz, MD University of California, San Francisco	Voices of Diversity: Older Adults with Multiple Chronic Conditions and Their Perspectives on Clinical Trials (Recording not available)
7/25/23	Christopher Almond, MD, MPH Stanford University	Pediatric Medical Devices - Challenges and Opportunities
3/8/22	Esteban Burchard, MD, MPH University of California, San Francisco	Race & Genetic Ancestry in Medicine. A Time for Reckoning Racism
3/10/21	Atul Butte, MD, PhD University of California, San Francisco	Precisely practicing medicine for COVID, from a half million tested patients and a trillion points of data
6/2/20	Matthew Porteus, MD, PhD Stanford University	Streamlining Genetic Safety Analysis for Ex Vivo Genome Edited Cell Therapies: Creating Safe and Efficacious Cellular Drugs using Genome Editing
10/2/19	Leslie Wilson, PhD University of California, San Francisco	Advances in Patient Preference Information to Enhance Benefit-Risk Assessment: Learning from Case Studies
11/5/18	Joseph DeRisi, PhD University of California, San Francisco	Chan-Zuckerberg Biohub (Recording not available)
9/12/17	Laura Esserman, MD, MBA University of California, San Francisco School of Medicine	OneSource Checklists: Tools for Integrating Care and Research and Catalyzing a Sea Change in the Practice of Medicine
5/11/17	Steven Goodman, MD, MHS, PhD Stanford University	Reproducibility in Medicine and Science
12/8/16	Joseph C. Wu, MD, PhD Stanford School of Medicine	Patient-Specific Stem Cells for Precision Medicine
11/30/16	Christopher (Chris) Ré, PhD Stanford University	DeepDive: A Data System for Macroscopic Science
10/26/16	Stephen Quake, PhD Stanford University	A Molecular Stethoscope